BMS bags US approval for Onureg
The oral therapy can be used as continued treatment for adults in first remission with acute myeloid leukaemia (AML)
Read More
Tag: Onureg
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
